Topper James N

CIK 000134138221 companiesSAN CARLOS, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001341382

Recent Transactions

50 trades

Award
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock
2026-05-19+24,122→ 66,718 total
Purchase
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-09-15$23.70/sh+660→ 3,028,524 total
Purchase
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-09-08$24.99/sh+1,260→ 3,027,864 total
Purchase
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-08-11$23.98/sh+471→ 3,026,604 total
Purchase
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-06-25$18.26/sh+1,260→ 3,026,133 total
Purchase
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-06-24$18.43/sh+2,520→ 3,024,873 total
Purchase
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-06-16$19.50/sh+8,584→ 3,022,153 total
Award
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock
2025-06-03+10,500→ 42,596 total
Award
Phathom Pharmaceuticals, Inc.$PHAT
Stock Option (Right to Buy)
2025-06-03+17,500→ 17,500 total
Purchase
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock
2025-05-21$3.86/sh+3,780→ 59,403 total
Purchase
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock
2025-05-14$3.32/sh+6,300→ 55,623 total
Purchase
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock
2025-05-13$3.16/sh+1,120→ 49,323 total
Purchase
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock
2025-05-12$3.04/sh+12,601→ 48,203 total
Purchase
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock
2025-05-09$3.19/sh+33,376→ 33,376 total
Purchase
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock
2025-05-09$3.62/sh+2,226→ 35,602 total
Purchase
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-03-26$22.49/sh+1,135→ 3,013,569 total
Purchase
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-03-04$21.02/sh+4,005→ 3,012,434 total
Award
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock
2024-05-23+10,500→ 32,096 total
Award
Phathom Pharmaceuticals, Inc.$PHAT
Stock Option (Right to Buy)
2024-05-23−17,500→ 17,500 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−10,000→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−7,650→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−7,650→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−7,650→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−17,500→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−7,650→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−10,000→ 0 total
Disposition from Tender
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-05-18−2,829,347→ 0 total
Exercise of In-Money
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-04-25$0.00/sh+1,200,000→ 2,829,366 total
Sale
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-04-25$64.57/sh−19→ 2,829,347 total
Exercise of In-Money
ALPINE IMMUNE SCIENCES, INC.
Warrant (Right to Buy)
2024-04-25−1,200,000→ 0 total
Purchase
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2024-03-26$21.50/sh+8,429→ 3,008,429 total
Award
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-01-02+17,500→ 17,500 total
Exercise of In-Money
ALPINE IMMUNE SCIENCES, INC.
Warrant (Right to Buy)
2023-12-11−145,251→ 0 total
Exercise of In-Money
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2023-12-11$12.74/sh+145,251→ 1,629,366 total
Award
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock
2023-05-25+9,000→ 21,596 total
Award
Phathom Pharmaceuticals, Inc.$PHAT
Stock Option (Right to Buy)
2023-05-25+15,000→ 15,000 total
Award
ANAPTYSBIO, INC$ANAB
Stock Option (right to buy)
2023-01-06+10,600→ 10,600 total
Award
ANAPTYSBIO, INC$ANAB
Restricted Stock Unit
2023-01-06+3,900→ 3,900 total
Award
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2023-01-03+10,000→ 10,000 total
Award
Phathom Pharmaceuticals, Inc.$PHAT
Stock Option (Right to Buy
2022-09-22+20,000→ 20,000 total
Award
ANAPTYSBIO, INC$ANAB
Stock Option (right to buy)
2022-02-10+9,200→ 9,200 total
Award
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2022-01-03+10,000→ 10,000 total
Award
ANAPTYSBIO, INC$ANAB
Stock Option (right to buy)
2021-02-10+11,000→ 11,000 total
Award
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2021-01-04+7,650→ 7,650 total
Purchase
Frazier Lifesciences Acquisition Corp
Class A Ordinary Shares
2020-12-11$10.00/sh+1,000,000→ 1,000,000 total
Award
Frazier Lifesciences Acquisition Corp
Class A Ordinary Shares
2020-12-11$10.00/sh+501,000→ 501,000 total
Award
Frazier Lifesciences Acquisition Corp
Warrants
2020-12-11+167,000→ 167,000 total
Award
Frazier Lifesciences Acquisition Corp
Warrants
2020-12-11+333,333→ 333,333 total
Award
Allena Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-11-17+14,000→ 14,000 total
Other
ANAPTYSBIO, INC$ANAB
Common Stock
2020-11-16+22,604→ 54,458 total

Recent Filings

Address

C/O ATTOVIA THERAPEUTICS, INC. 1091 INDUSTRIAL ROAD, SUITE 310

SAN CARLOS, CA, 94070

View on SEC.gov